Skip to content

Chidimma Okwara, MD

NPI 1356032536ActiveIndividual· General Practice· Houston, TX

General Practice (MD) in Houston, Texas, licensed in TX, with an NPI issued in May 2023. Part D covered 34 prescriptions written in 2024, 74% of them generic. Arcutis Biotherapeutics, Inc. was the largest of 3 companies reporting payments in 2025, $389.70 in all, mostly food and beverage.

Overview

NPI1356032536
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorYes
NPI issuedMay 17, 2023
Last updated in NPPESOct 22, 2024
Certified by providerOct 22, 2024

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)34 · 45 30-day fills
Total drug cost$4,941
Generic share74% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$389.70 · 3 payments from 3 companies

Top paying companies in 2025

CompanyAmountPayments
Arcutis Biotherapeutics, Inc.$160.311
Genzyme Corporation$125.031
Abbvie Inc.$104.361

What the 2025 payments were for

  • Food and Beverage$389.70 · 3 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other general practitioners in Houston

All 322 general practitioners in Houston · All general practitioners in Texas